When it was revealed on March 16 that Cincinnati Bengals linebacker Vontaze Burfict was facing a four-game suspension by the National Football League for violating its performance-enhancing drug policy, it was old news for the organization. Burfict tested positive before the season ended on Dec. 31, and the club has been waiting for an arbitrator to hear 27-year-old linebacker’s appeal. The Bengals have been operating since then with the knowledge he could miss the start of the 2018 season. “We were aware of it since the end of the season so whatever happens, happens. It doesn’t hold us back,” Bengals head coach Marvin Lewis told The Enquirer. “We’re going to miss a player, likely, for a few weeks, but there’s nothing we can do about it. That’s the way it goes. You’ve got to do things within the scope of what the players are asked to do all the time, and that’s important. Just gotta do it the right way.” ESPN and ProFootballTalk.com outlined several different theories as for why Burfict tested positive for a banned substance and the potential basis of his appeal, ranging from prescribed pain medications to his use of Adderall to the fact he did not play in the final week of the regular season.